Twist Gross Profit from 2010 to 2024

TWST Stock

USD 42.23 0.57 1.37%

Twist Bioscience Gross Profit yearly trend continues to be comparatively stable with very little volatility. Gross Profit is likely to outpace its year average in 2024. Gross Profit is the profit Twist Bioscience Corp makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2016-09-30

Previous Quarter

35.3 M

Current Value

38.2 M

Quarterly Volatility

12.8 M

Covid

Check Twist Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Twist Bioscience's main balance sheet or income statement drivers, such as Tax Provision of 588 K, Net Interest Income of 16.1 M or Interest Income of 16.1 M, as well as many indicators such as Price To Sales Ratio of 7.96, Dividend Yield of 0.0 or PTB Ratio of 5.82. Twist financial statements analysis is a perfect complement when working with Twist Bioscience Valuation or Volatility modules.

Check out the analysis of Twist Bioscience Correlation against competitors.

Latest Twist Bioscience's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Twist Bioscience Corp over the last few years. Gross profit is a required income statement account that reflects total revenue of Twist Bioscience Corp minus its cost of goods sold. It is profit before Twist Bioscience operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Twist Bioscience's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Twist Bioscience's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 84.23 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Twist Gross Profit Regression Statistics

	Arithmetic Mean	31,451,230
	Geometric Mean	19,179,285
	Coefficient Of Variation	173.67
	Mean Deviation	45,571,507
	Median	(6,762,000)
	Standard Deviation	54,622,061
	Sample Variance	2983.6T
	Range	153.3M
	R-Value	0.87
	Mean Square Error	754.3T
	R-Squared	0.77
	Significance	0.00002
	Slope	10,684,418
	Total Sum of Squares	41770T

Twist Gross Profit History

	2024	140 M
	2023	133.3 M
	2022	89.7 M
	2021	84.2 M
	2020	51.7 M
	2019	28.7 M
	2018	7 M

Other Fundumenentals of Twist Bioscience Corp

Gross Profit Margin

Twist Bioscience Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Short Term Investments	Long Term Debt Total	Capital Surpluse	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Property Plant Equipment	Net Invested Capital	Net Working Capital	Deferred Long Term Liab	Common Stock
Total Assets		0.98	0.9	0.16	-0.87	-0.84	0.75	-0.89	0.97	0.8	0.41	-0.76	0.9	-0.18	-0.21	0.98	0.72	0.88	0.79	0.89	0.97	-0.25	0.89
Total Stockholder Equity	0.98		0.9	0.23	-0.84	-0.82	0.73	-0.9	0.96	0.76	0.5	-0.86	0.89	-0.36	-0.23	0.97	0.71	0.84	0.75	0.9	0.96	-0.23	0.85
Net Tangible Assets	0.9	0.9		0.0	-0.72	-0.98	0.44	-0.91	0.92	0.93	0.42	-0.84	1.0	-0.33	-0.26	0.86	0.9	0.74	0.93	0.87	0.85	-0.61	0.96
Current Deferred Revenue	0.16	0.23	0.0		-0.42	0.07	0.37	-0.33	0.15	-0.33	0.22	-0.29	0.01	-0.39	0.18	0.34	0.07	-0.16	-0.35	-0.09	0.36	0.29	-0.08
Net Debt	-0.87	-0.84	-0.72	-0.42		0.65	-0.77	0.75	-0.77	-0.58	-0.11	0.59	-0.73	0.07	0.21	-0.92	-0.59	-0.71	-0.54	-0.56	-0.92	0.16	-0.73
Retained Earnings	-0.84	-0.82	-0.98	0.07	0.65		-0.36	0.89	-0.89	-0.95	-0.33	0.73	-0.98	0.2	0.2	-0.79	-0.92	-0.69	-0.95	-0.83	-0.77	0.67	-0.96
Accounts Payable	0.75	0.73	0.44	0.37	-0.77	-0.36		-0.57	0.66	0.33	0.26	-0.43	0.45	-0.02	-0.08	0.77	0.15	0.77	0.31	0.59	0.75	0.29	0.39
Long Term Debt	-0.89	-0.9	-0.91	-0.33	0.75	0.89	-0.57		-0.94	-0.74	-0.57	0.82	-0.92	0.35	0.11	-0.91	-0.84	-0.64	-0.74	-0.83	-0.9	0.44	-0.84
Net Receivables	0.97	0.96	0.92	0.15	-0.77	-0.89	0.66	-0.94		0.81	0.5	-0.79	0.92	-0.25	-0.17	0.94	0.77	0.82	0.81	0.93	0.92	-0.3	0.89
Good Will	0.8	0.76	0.93	-0.33	-0.58	-0.95	0.33	-0.74	0.81		0.22	-0.63	0.93	-0.07	-0.26	0.7	0.83	0.76	1.0	0.82	0.69	-0.68	0.94
Short Term Investments	0.41	0.5	0.42	0.22	-0.11	-0.33	0.26	-0.57	0.5	0.22		-0.61	0.4	-0.56	0.09	0.46	0.35	0.26	0.26	0.64	0.46	-0.09	0.3
Long Term Debt Total	-0.76	-0.86	-0.84	-0.29	0.59	0.73	-0.43	0.82	-0.79	-0.63	-0.61		-0.81	0.77	0.27	-0.77	-0.68	-0.55	-0.63	-0.78	-0.77	0.36	-0.7
Capital Surpluse	0.9	0.89	1.0	0.01	-0.73	-0.98	0.45	-0.92	0.92	0.93	0.4	-0.81		-0.28	-0.23	0.86	0.91	0.73	0.93	0.86	0.86	-0.62	0.96
Total Liab	-0.18	-0.36	-0.33	-0.39	0.07	0.2	-0.02	0.35	-0.25	-0.07	-0.56	0.77	-0.28		0.18	-0.24	-0.23	0.02	-0.08	-0.3	-0.26	0.13	-0.12
Short Long Term Debt	-0.21	-0.23	-0.26	0.18	0.21	0.2	-0.08	0.11	-0.17	-0.26	0.09	0.27	-0.23	0.18		-0.18	-0.03	-0.22	-0.25	-0.15	-0.19	0.17	-0.26
Total Current Assets	0.98	0.97	0.86	0.34	-0.92	-0.79	0.77	-0.91	0.94	0.7	0.46	-0.77	0.86	-0.24	-0.18		0.71	0.8	0.68	0.82	1.0	-0.22	0.84
Short Term Debt	0.72	0.71	0.9	0.07	-0.59	-0.92	0.15	-0.84	0.77	0.83	0.35	-0.68	0.91	-0.23	-0.03	0.71		0.45	0.82	0.66	0.71	-0.77	0.91
Intangible Assets	0.88	0.84	0.74	-0.16	-0.71	-0.69	0.77	-0.64	0.82	0.76	0.26	-0.55	0.73	0.02	-0.22	0.8	0.45		0.75	0.84	0.78	-0.11	0.74
Property Plant Equipment	0.79	0.75	0.93	-0.35	-0.54	-0.95	0.31	-0.74	0.81	1.0	0.26	-0.63	0.93	-0.08	-0.25	0.68	0.82	0.75		0.83	0.67	-0.69	0.93
Net Invested Capital	0.89	0.9	0.87	-0.09	-0.56	-0.83	0.59	-0.83	0.93	0.82	0.64	-0.78	0.86	-0.3	-0.15	0.82	0.66	0.84	0.83		0.8	-0.29	0.8
Net Working Capital	0.97	0.96	0.85	0.36	-0.92	-0.77	0.75	-0.9	0.92	0.69	0.46	-0.77	0.86	-0.26	-0.19	1.0	0.71	0.78	0.67	0.8		-0.24	0.84
Deferred Long Term Liab	-0.25	-0.23	-0.61	0.29	0.16	0.67	0.29	0.44	-0.3	-0.68	-0.09	0.36	-0.62	0.13	0.17	-0.22	-0.77	-0.11	-0.69	-0.29	-0.24		-0.62
Common Stock	0.89	0.85	0.96	-0.08	-0.73	-0.96	0.39	-0.84	0.89	0.94	0.3	-0.7	0.96	-0.12	-0.26	0.84	0.91	0.74	0.93	0.8	0.84	-0.62

Click cells to compare fundamentals

About Twist Bioscience Financial Statements

Twist Bioscience shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although Twist Bioscience investors may analyze each financial statement separately, they are all interrelated. The changes in Twist Bioscience's assets and liabilities, for example, are also reflected in the revenues and expenses on on Twist Bioscience's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Gross Profit	133.3 M	140 M
Gross Profit Margin	0.43	0.45

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Twist Stock Analysis

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC